from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0471c/-

LFCtreatmentdescriptionclass of inhibitor

-0.084

Amikacinug/mL Amikacintranslation

1.366

Cap5-10ug/mL Capreomycintranslation

0.127

Rox10-50 ug/mL Roxithromycintranslation

0.556

SM2-5 ug/mL Streptomycintranslation

1.544

Tet5-10 ug/mL Tetracyclinetranslation

-1.139

Rif0.2-5ug/mL Rifampicintranscription

-0.991

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.171

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.586

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.525

CPZ10-50 ug/mL Chlorpromazinerespiration

1.530

Clofazimine10-13 ug/mL Clofaziminerespiration

0.903

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.306

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.513

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.511

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.874

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.482

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.817

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.245

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.351

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.134

KCN5-20 ug/mL Potassium cyaniderespiration

1.953

NaN30.2-2 mM Sodium aziderespiration

0.550

Nigericin50 uM Nigericinrespiration

-0.097

TRC10-150 ug/mL Triclosanrespiration

0.808

TRZ10-25 ug/mL Thioridazinerespiration

1.288

Valinomycin0.5-10 uM Valinomycinrespiration

-2.019

ZnSO42 mM ZnSO4respiration

0.194

menadione6-10 ug/mL Menadionerespiration

0.324

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.186

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.233

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.128

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.215

NRP_1Non-replicating persistence stage 1dosRassociated

-0.131

Amp0.2mg/mL AmpicillincellWall

-0.214

Cephalexin20-100 ug/mL CephalexincellWall

-0.124

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.378

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.242

EMB10-20 ug/mL EthambutolcellWall

-0.625

Eta12-40 ug/mL EthionamidecellWall

-0.431

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.116

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.833

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.636

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.284

BZA0.12 mg/mL BenzamidearomaticAmides

-0.988

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.320

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.177

H2O24 mM hydrogen peroxideDNAdamaging

0.369

Levo10 ug/mL LevofloxacinDNAdamaging

-0.665

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.525

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.105

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.614

UVUV-irradiationDNAdamaging

0.159

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.224

Antimycin12.5-50 ug/mL Antimycin A?

0.470

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.027

PA_110-50 ug/mL Antitubercular compound PA-1?

0.170

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.111

PA8240.2-2 ug/mL PA-824?

0.225

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.511

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.784

Verapamil50 uM Verapamil?

-0.073

mercaptoethanol2 mM 2-Mercaptoethanol?

0.581

methoxatin10-20 ug/mL Methoxatin?